Pharmacology, Toxicology and Pharmaceutical Science
B Cell Lymphoma
100%
Protein P53
100%
Mouse Mutant
66%
Tumor Suppressor Protein
66%
Neoplasm
33%
Malignant Neoplasm
33%
Inflammation
33%
Carcinogenesis
33%
Benign Neoplasm
33%
Adenoma
33%
Cancer Staging
33%
Galactosidase
33%
Disease Predisposition
33%
Chromosomal Instability
33%
Hemangioma
33%
Cystadenoma
33%
Lymphoid Hyperplasia
33%
Keyphrases
Gene-deficient Mice
100%
B-cell Lymphoma
100%
Proliferative Lesions
100%
Murine Double Minute 2 (MDM2)
100%
Spleen
18%
Mutant Mice
18%
Systemic Inflammation
9%
Cell Proliferation
9%
Tumor Suppressor
9%
P53 Expression
9%
Age-matched
9%
β-Galactosidase (β-Gal)
9%
Benign Tumor
9%
Adenoma
9%
Tumorigenesis
9%
Endogenous Genes
9%
Splenic B Cells
9%
Tumor Suppressor Activity
9%
Tumor Protein p53 (TP53)
9%
Early Cancer
9%
Cassette
9%
P53 Activity
9%
Marginal Zone B Cells
9%
Genome Maintenance
9%
Tumor-free
9%
Hemangioma
9%
P53 Pathway
9%
Gene Trap
9%
Tip60
9%
White Pulp
9%
Selective Expansion
9%
Reactive Lymphoid Hyperplasia
9%
Splenic White Pulp
9%
Chromosomal Stability
9%
Harderian Gland
9%
Pulmonary Papillary Adenoma
9%
Anticancer Pathways
9%
Immunology and Microbiology
P53
100%
B Cell
100%
Wild Type
66%
Mouse Mutant
66%
Downregulation
33%
Cancer Staging
33%
Cell Proliferation
33%
Splenic B Cell
33%
Systemic Inflammation
33%
Chromosomal Instability
33%
Marginal Zone B-Cell
33%
Galactosidase
33%
Medicine and Dentistry
B-Cell Lymphoma
100%
Mdm2
100%
Protein P53
27%
Tumor Suppressor Protein
18%
Malignant Neoplasm
9%
Neoplasm
9%
Cell Proliferation
9%
Downregulation
9%
Disease Predisposition
9%
Benign Tumor
9%
Carcinogenesis
9%
Cancer Staging
9%
Splenic B Cell
9%
Adenoma
9%
Chromosomal Instability
9%
Lymphoid Hyperplasia
9%
Hemangioma
9%
Cystadenoma
9%
Galactosidase
9%
Marginal Zone B Cell
9%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Mdm2
100%
P53
27%
Wild Type
18%
Tumor Suppressor Protein
18%
Mouse Mutant
18%
Downregulation
9%
Carcinogenesis
9%
Chromosome Instability
9%
Cell Proliferation
9%
Anticancer
9%
Cancer Staging
9%
Marginal Zone B-Cell
9%
Galactosidase
9%